Author: WTN News

Technically skilled people can be lone wolves and tend to have no appetite for managing people, let alone setting business strategy as part of upper management. How, then, do the chief information officers that manage them keep them motivated when they advance to that point...

Affymetrix executive Chris Kendrick-Parker will help direct the future of GenTel Biosciences after his appointment to the company's Board of Directors. Kendrick-Parker brings more than 20 years of experience in the life science industry to the GenTel Board, including management of sales and marketing for...

Wisconsin lost one of its most charismatic governors last week with the passing of Lee Sherman Dreyfus. In this edition of Inside Wisconsin, columnist Tom Still, who covered the Dreyfus Administration as a young reporter, remembers the former University of Wisconsin-Stevens Point chancellor, who as...

A molecular diagnostic assay that simultaneously detects and differentiates several types of influenza in a single specimen has been cleared for marketing by the Food and Drug Administration. The product, developed by the Milwaukee-based Prodesse, is the first cleared infectious disease test to detect as...

The incentive stock option, commonly called an “ISO,” may carry a litany of requirements, and the dreaded ATM tax can rear its ugly head, but legal columnist Sverre Roang believes this option can be very beneficial for employees of early-stage and technology companies. In this...

What are the real issues that all the prognosticators seem to overlook with their presidential candidate analysis and predictions? They are almost too numerous to count, especially when it comes to the future of technology and network infrastructure, says columnist James Carlini. In this edition...

Is TomoTherapy's stock suddenly dropping? Its common stock was down, temporarily at least, on the news that a competitor has received FDA clearance for a radiation therapy product to rival TomoTherapy's Hi-Art System. That competitor, Varian Medical systems, is drawing praise from market analysts who...

UW-Madison's master of science in biotechnology degree responds to the realities of technology commercialization, where market potential, scientific merit, and government regulations collide. The program, which integrates content from six UW-Madison colleges, emphasizes cross-disciplinary learning in its attempt to take a comprehensive approach to business,...

Diminishing oil reserves and the threat of global warming caused by releasing carbon into the atmosphere have researchers searching for a sustainable, carbon-neutral fuel to reduce our reliance on fossil fuels. UW-Madison researcher James Dumesic has created a path to such a fuel, and his...